HEALTH TECHNOLOGY ASSESSMENT – IS IT THE WAY TO SEARCH FOR COST – EFFECTIVE MEDICINES IN CENTRAL AND EASTERN EUROPE?

by Marcin Czech
Published 2011-07-01

Multi-Criteria Decision Analysis (MCDA) Models in Health Technology Assessment of Orphan Drugs—a Systematic Literature Review. Next Steps in Methodology Development?

by Aleksandra Baran-Kooiker, Marcin Czech, Marcin Czech, Coen Kooiker
Published 2018-10-01

E-prescription pilot in Poland allows for identification and analysis of primary nonadherence drivers

by Przemysław Kardas, Janusz Cieszynski, Marcin Czech, Paweł Lewek
Published 2019-08-01

Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens

by Przemysław Kardas, Filip Urbański, Aneta Lichwierowicz, Ewa Chudzyńska, Grzegorz Kardas, Marcin Czech
Published 2021-04-01

The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National...

by Przemysław Kardas, Filip Urbański, Aneta Lichwierowicz, Ewa Chudzyńska, Marcin Czech, Katarzyna Makowska, Grzegorz Kardas
Published 2021-01-01

Do Advanced Therapies Have a Future in the Low- and Middle-Income Countries - The Case of Bulgaria, Romania, and Poland

by Maria Kamusheva, Adina Turcu-Stiolica, Jakub Gierczyński, Mihaela-Simona Subtirelu, Marcin Czech, Guenka Petrova
Published 2021-08-01

The Potential to Reduce Patient Co-Payment and the Public Payer Spending in Poland through an Optimised Implementation of the Generic Substitution: The Win-Win Scenario Suggested b...

by Przemysław Kardas, Aneta Lichwierowicz, Filip Urbański, Beata Szadkowska-Opasiak, Ewa Karasiewicz, Paweł Lewek, Dominika Krupa, Marcin Czech
Published 2021-07-01

Measuring quality, equity, outcomes and efficiency in pharmaceutical care as a part of managed care

by Tomasz Hermanowski, Chris L. Pashos, Sylwia I. Szafraniec-Burylo, Aleksandra N. Krancberg, Marta Kowalczyk, Malgorzata Chmielewska, Marcin Czech
Published 2013-10-01

Measuring quality, equity, outcomes and efficiency in pharmaceutical care as a part of managed care

by Tomasz Hermanowski, Chris L. Pashos, Sylwia I. Szafraniec-Burylo, Aleksandra N. Krancberg, Marta Kowalczyk, Malgorzata Chmielewska, Marcin Czech
Published 2013-10-01

Flu Vaccinations in Pharmacies—A Review of Pharmacists Fighting Pandemics and Infectious Diseases

by Marcin Czech, Marcin Balcerzak, Adam Antczak, Michał Byliniak, Elżbieta Piotrowska-Rutkowska, Mariola Drozd, Grzegorz Juszczyk, Urszula Religioni, Regis Vaillancourt, Piotr Merks
Published 2020-10-01

Expectations towards coordinated care in Poland: patient opinion survey

by Katarzyna Wiktorzak, Sylwia Szafraniec-Buryło, Dariusz Dziełak, Iwona Poznerowicz, Katarzyna Kułaga, Magdalena Bogdan, Grzegorz Bukato, Donata Kurpas, Marcin Czech, Andrzej Śliwczyński
Published 2019-08-01

Primary Health Care PLUS project in Poland: disease management programs

by Katarzyna Wiktorzak, Sylwia Szafraniec-Buryło, Katarzyna Klonowska, Katarzyna Iłowiecka, Dariusz Dziełak, Magdalena Bogdan, Grzegorz Bukato, Marcin Czech, Donata Kurpas, Andrzej Śliwczyński
Published 2019-08-01

Communication strategy in Primary Health Care plus project in Poland

by Katarzyna Wiktorzak, Sylwia Szafraniec-Buryło, Agata Szymczak, Marta Morawska, Sabina Karczmarz, Dariusz Dziełak, Magdalena Bogdan, Donata Kurpas, Marcin Czech, Andrzej Śliwczyński
Published 2019-08-01

Chronic heart failure management in primary healthcare in Poland: Results of a nationwide cross-sectional study

by Barbara Wizner, Małgorzata Fedyk-Łukasik, Grzegorz Opolski, Tomasz Zdrojewski, Adam Windak, Marcin Czech, Jacek S. Dubiel, Michał Marchel, Krzysztof Rewiuk, Tomasz Rywik, Jerzy Korewicki, Tomasz Grodzicki
Published 2018-01-01

Availability and quality of data on pharmaceutical benefit financing components of health care system in United States, United Kingdom, Denmark, Germany, Italy and Poland

by Tomasz Hermanowski, Sylwia I. Szafraniec-Burylo, Urszula Cegłowska, Aleksandra Drozdowska, Dominika Duleba, Marta Kowalczyk, Aleksandra N. Krancberg, Chris L. Pashos, Andrzej Szczypior, Malgorzata Chmielewska, Marcin Czech
Published 2013-10-01

Availability and quality of data on pharmaceutical benefit financing components of health care system in United States, United Kingdom, Denmark, Germany, Italy and Poland

by Tomasz Hermanowski, Sylwia I. Szafraniec-Burylo, Urszula Cegłowska, Aleksandra Drozdowska, Dominika Duleba, Marta Kowalczyk, Aleksandra N. Krancberg, Chris L. Pashos, Andrzej Szczypior, Malgorzata Chmielewska, Marcin Czech
Published 2013-10-01

A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries

by Marcin Czech, Aleksandra Baran-Kooiker, Kagan Atikeler, Kagan Atikeler, Maria Demirtshyan, Kamilla Gaitova, Malwina Holownia-Voloskova, Malwina Holownia-Voloskova, Adina Turcu-Stiolica, Coen Kooiker, Oresta Piniazhko, Natella Konstandyan, Olha Zalis'ka, Jolanta Sykut-Cegielska
Published 2020-01-01

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries

by Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trąbka, Marcin Czech, Guenka Petrova, Manoela Manova, Manoela Manova, Alexandra Savova, Alexandra Savova, Pero Draganić, Pero Draganić, Lenka Vostalová, Juraj Slabý, Agnes Männik, Kristóf Márky, Zinta Rugaja, Jolanta Gulbinovic, Tomas Tesar, Marian Sorin Paveliu
Published 2019-05-01